David Meeker, who has led Genzyme since Sanofi SA took over the US specialty pharma company in 2011, is to step down at the end of June to make way for Bill Sibold, head of Genzyme’s multiple sclerosis, oncology and immunology businesses. ---Subscribe to MedNous to access this article--- Company News
